JANESSA MORRIS: Open Payments
NPI 1871148833 · MONACA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 34 payments from 9 companies in 2025. Trend: 2023 $309 · 2024 $406 · 2025 $658
Food & beverage: $643Education: $15
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $181 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| Lilly USA, LLC | 4 | $93 |
| Novo Nordisk Inc | 4 | $74 |
| ABBVIE INC. | 3 | $53 |
| Amgen Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TRELEGY ELLIPTA, BREZTRI, MOUNJARO, FARXIGA, Ozempic, GEMTESA, UBRELVY, ACCRUFER.
Industry payments across PA — which companies pay providers there.
